Charter 2 & 3: Breast cancer heterogeneity and evolution

Back

Charter 2 & 3: Breast cancer heterogeneity and evolution

09.35
Genomic hetererogeneity of breast cancer
Dr Lucy Yates

09.55
Experimental modelling of heterogeneity
Dr Rachael Natrajan

10.15
Relevance to the histopathologist
Dr Fraser Symmans

10.35
Selected Free Communication
Comparative transcriptomic analysis of long-term neoadjuvant letrozole-treated dormant and acquired resistant tumours using sequential clinical samples
Dr Cigdem Selli, Edinburgh

Chairs: Professor Stephen Johnston & Professor Carlos Caldas